Pharmaron Beijing Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 21,370 full-time employees. The company went IPO on 2019-01-28. Pharmaron Beijing Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The firm operates through five segments. The Laboratory Services segment includes laboratory chemistry and bioscience services, covering small molecule drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates, and cell and gene therapy products. The Chemical and Formulation Process Development and Manufacturing Services segment includes active pharmaceutical ingredient process development and manufacturing, as well as preformulation and formulation development. The Clinical Research Services segment includes international and domestic clinical research services. The Large Molecule and Cell and Gene Therapy Services segment includes large molecule drug discovery, development, and manufacturing services, as well as cell and gene therapy laboratory and gene therapy drug development and manufacturing services. The firm also operates through the others segment.
Follow-Up Questions
Pharmaron Beijing Co Ltd のCEOは誰ですか？
Mr. Boliang Lou は Pharmaron Beijing Co Ltd の Executive Chairman of the Board で、2016 から在籍しています。
PHBBF の株価パフォーマンスは？
PHBBF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Pharmaron Beijing Co Ltd の主な事業テーマや業界は？
Pharmaron Beijing Co Ltd は Life Sciences Tools & Services 業界、セクターは Health Care に属しています。
